Moody National Bank Trust Division Has $1.99 Million Stake in Evolent Health, Inc. (NYSE:EVH)

Moody National Bank Trust Division increased its stake in shares of Evolent Health, Inc. (NYSE:EVH) by 4.4% in the 4th quarter, HoldingsChannel.com reports. The firm owned 176,653 shares of the technology company’s stock after buying an additional 7,450 shares during the quarter. Moody National Bank Trust Division’s holdings in Evolent Health were worth $1,987,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also modified their holdings of the company. Wellington Management Group LLP raised its stake in shares of Evolent Health by 12.8% during the 3rd quarter. Wellington Management Group LLP now owns 12,595,459 shares of the technology company’s stock worth $356,200,000 after purchasing an additional 1,426,747 shares in the last quarter. Point72 Asset Management L.P. raised its holdings in shares of Evolent Health by 1,948.5% during the 3rd quarter. Point72 Asset Management L.P. now owns 1,495,385 shares of the technology company’s stock valued at $42,289,000 after purchasing an additional 1,422,385 shares in the last quarter. First Light Asset Management LLC lifted its stake in shares of Evolent Health by 401.5% in the 2nd quarter. First Light Asset Management LLC now owns 1,445,305 shares of the technology company’s stock valued at $27,634,000 after purchasing an additional 1,157,124 shares during the last quarter. Bellevue Group AG boosted its stake in shares of Evolent Health by 59.9% during the 3rd quarter. Bellevue Group AG now owns 2,670,050 shares of the technology company’s stock worth $75,509,000 after acquiring an additional 1,000,215 shares in the last quarter. Finally, Engaged Capital LLC raised its stake in shares of Evolent Health by 26.1% in the 2nd quarter. Engaged Capital LLC now owns 4,111,458 shares of the technology company’s stock valued at $78,611,000 after acquiring an additional 850,000 shares in the last quarter.

Evolent Health Price Performance

Shares of NYSE EVH traded down $0.20 during midday trading on Monday, reaching $12.34. 489,018 shares of the company traded hands, compared to its average volume of 1,421,437. The firm has a market cap of $1.44 billion, a PE ratio of -13.56 and a beta of 1.45. The company has a debt-to-equity ratio of 0.58, a quick ratio of 1.04 and a current ratio of 1.04. The stock’s 50-day simple moving average is $12.91 and its 200-day simple moving average is $21.03. Evolent Health, Inc. has a 12 month low of $10.53 and a 12 month high of $35.00.

Wall Street Analysts Forecast Growth

Several brokerages have commented on EVH. Royal Bank of Canada reiterated an “outperform” rating and set a $20.00 price target on shares of Evolent Health in a report on Tuesday, November 12th. BTIG Research decreased their target price on Evolent Health from $36.00 to $29.00 and set a “buy” rating for the company in a research note on Tuesday, December 3rd. Barclays dropped their target price on shares of Evolent Health from $39.00 to $19.00 and set an “overweight” rating on the stock in a research report on Monday, November 11th. KeyCorp initiated coverage on shares of Evolent Health in a research report on Friday, October 11th. They set an “overweight” rating and a $35.00 price objective for the company. Finally, Oppenheimer decreased their price objective on Evolent Health from $34.00 to $28.00 and set an “outperform” rating on the stock in a report on Monday, November 18th. One analyst has rated the stock with a hold rating, ten have assigned a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, the company has an average rating of “Buy” and a consensus target price of $22.83.

About Evolent Health

Evolent Health, Inc, through its subsidiary, Evolent Health LLC, offers specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company provides platform for health plan administration and value-based business infrastructure. It offers administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients.